Disc Medicine, Inc.

IRON · Nasdaq · SIC 2834: Pharmaceutical Preparations
134
SEC Filings

Business Summary

1 Item 1A. Risk Factors 46 Item 1B. Unresolved Staff Comments 98 Item 1C. Cybersecurity 98 Item 2. Properties 98 Item 3. Legal Proceedings 99 Item 4. Mine Safety Disclosures 99 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 100 Item 6. Reserved 101 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 102 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 111 Item ...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIRONdiscussed_in_filing Cybersecurity
topic_mentionIRONdiscussed_in_filing Cybersecurity
topic_mentionIRONdiscussed_in_filing Cybersecurity
topic_mentionIRONdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-073602EDGAR118K words
2025-02-272024-12-310000950170-25-028390EDGAR
2024-03-212023-12-310000950170-24-034432EDGAR
2023-03-312022-12-310000950170-23-011139EDGAR
2022-03-102021-12-310000950170-22-003288EDGAR
2021-03-292020-12-310001213900-21-018272EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268200EDGAR72K words
2025-08-072025-06-300001816736-25-000007EDGAR
2025-05-072025-03-310000950170-25-065069EDGAR
2024-11-122024-09-300000950170-24-124650EDGAR
2024-08-082024-06-300000950170-24-093357EDGAR
2024-05-092024-03-310000950170-24-056304EDGAR
2023-11-092023-09-300000950170-23-061572EDGAR
2023-08-112023-06-300000950170-23-041594EDGAR
2023-05-152023-03-310000950170-23-021963EDGAR
2022-11-102022-09-300000950170-22-024195EDGAR
2022-08-112022-06-300000950170-22-016671EDGAR
2022-05-062022-03-310000950170-22-008015EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001193125-26-082855EDGAR1K words
2026-02-260001193125-26-073594EDGAR
2026-02-170001193125-26-053066EDGAR
2026-02-130001193125-26-051504EDGAR
2026-01-120001193125-26-009871EDGAR
2025-12-080001193125-25-310664EDGAR
2025-11-060001193125-25-268196EDGAR
2025-10-220001193125-25-245871EDGAR
2025-10-200001193125-25-242959EDGAR
2025-10-170001193125-25-242026EDGAR

134 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001816736
TickerIRON
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0a1011e523e9b33ee2f6eadfdf09ccf05624fc6c96fbbfcbed2019c6a0adc185
parent: 9f64ce5b2fbc6866b2ca1b4263e0f08c1d9b0097a619b79ec6293bf170758ff8
content hash: 887abdfe5517eb776bae2f3e381c7d42583de88af3c45502c4d393d8d70ca85e
signed: 2026-04-13T04:45:45.150Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf